RxSight (RXST) Total Non-Current Liabilities (2020 - 2025)
RxSight's (RXST) quarterly Total Non-Current Liabilities came in at $36.1 million in Q4 2025, up 1.42% YoY from $35.6 million in Q4 2024, and up 10.96% on a QoQ basis from $32.6 million in Q3 2025.
RxSight (RXST) Total Non-Current Liabilities (2020 - 2025) Analysis & Trends
RxSight (RXST) has 6 years of Total Non-Current Liabilities data on file, last reported at $36.1 million in Q4 2025.
- Quarterly Total Non-Current Liabilities rose 1.42% year-over-year to $36.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $36.1 million (up 1.42% YoY) and the FY2025 annual result came in at $36.1 million, up 1.42% from the prior year.
- Total Non-Current Liabilities climbed to $36.1 million in Q4 2025, from $32.6 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $60.3 million in Q4 2022 to a low of $19.2 million in Q1 2024.
- A 5-year average of $36.8 million and a median of $33.7 million in 2025 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Non-Current Liabilities sank 63.3% — and 2025, when it surged 75.34%.
- Tracing RXST's Total Non-Current Liabilities over 5 years: stood at $54.5 million in 2021, then grew by 10.62% to $60.3 million in 2022, then slumped by 63.3% to $22.1 million in 2023, then soared by 61.1% to $35.6 million in 2024, then grew by 1.42% to $36.1 million in 2025.
- The last three Total Non-Current Liabilities figures came in at $36.1 million (Q4 2025), $32.6 million (Q3 2025), and $31.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.25 Bn | 196.65 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.36 Bn | 123.89 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 119.03 Bn | 109.81 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 74.45 Bn | 73.91 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.81 Bn | 47.55 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 35.04 Bn | 33.10 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.84 Bn | 31.73 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.25 Bn | 22.93 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.18 Bn | 22.70 Bn | 684.20 Mn | 3.44 Bn |
| 10 | RxSight | 259.94 Mn | -144.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 36.13 Mn |
| Sep 30, 2025 | 32.56 Mn |
| Jun 30, 2025 | 31.00 Mn |
| Mar 31, 2025 | 33.73 Mn |
| Dec 31, 2024 | 35.63 Mn |
| Sep 30, 2024 | 33.21 Mn |
| Jun 30, 2024 | 30.29 Mn |
| Mar 31, 2024 | 19.24 Mn |
| Dec 31, 2023 | 22.11 Mn |
| Sep 30, 2023 | 20.30 Mn |
| Jun 30, 2023 | 38.00 Mn |
| Dec 31, 2022 | 60.26 Mn |
| Dec 31, 2021 | 54.48 Mn |
| Sep 30, 2021 | 52.85 Mn |
| Jun 30, 2021 | 52.37 Mn |
| Dec 31, 2020 | 36.06 Mn |